GPC3 Promotes Lung Squamous Cell Carcinoma Progression and HLA-A2-Restricted GPC3 Antigenic Peptide-Modified Dendritic Cell-Induced Cytotoxic T Lymphocytes to Kill Lung Squamous Cell Carcinoma Cells

Lung squamous cell carcinoma (LUSC) is associated with poor clinical prognosis and lacks available targeted agents. GPC3 is upregulated in LUSC. Our study aimed to explore the roles of GPC3 in LUSC and the antitumor effects of HLA-A2-restricted GPC3 antigenic peptide-sensitized dendritic cell (DC)-i...

Descripción completa

Detalles Bibliográficos
Autores principales: Ning, Jing, Ding, Jianqiao, Wang, Shu, Jiang, Youhong, Wang, Daqing, Jiang, Shenyi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10643027/
https://www.ncbi.nlm.nih.gov/pubmed/37965271
http://dx.doi.org/10.1155/2023/5532617

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10643027/
https://www.ncbi.nlm.nih.gov/pubmed/37965271
http://dx.doi.org/10.1155/2023/5532617

Ejemplares similares